Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 227

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in a Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley

Open access
Steenland, Kyle, Zhao, Liping, Winquist, Andrea, Parks, Christine·2013·Environmental Health Perspectives
DOI 10.1289/ehp.1206449
Open this paper in CoChat — free account

Abstract

BACKGROUND: Little is known about environmental determinants of autoimmune diseases. OBJECTIVES: We studied autoimmune diseases in relation to level of exposure to perfluorooctanoic acid (PFOA), which was introduced in the late 1940s and is now ubiquitous in the serum of residents of industrialized countries. METHODS: In 2008-2011 we interviewed 32,254 U.S. adults with high serum PFOA serum levels (median, 28 ng/mL) associated with drinking contaminated water near a chemical plant. Disease history was assessed retrospectively from 1952 or birth (if later than 1952) until interview. Self-reported history of autoimmune disease was validated via medical records. Cumulative exposure to PFOA was derived from estimates of annual mean serum PFOA levels during follow-up, which were based on plant emissions, residential and work history, and a fate-transport model. Cox regression models were used to estimate associations between quartiles of cumulative PFOA serum levels and the incidence of autoimmune diseases with ≥ 50 validated cases, including ulcerative colitis (n = 151), Crohn's disease (n = 96), rheumatoid arthritis (n = 346), insulin-dependent diabetes (presumed to be type 1) (n = 160), lupus (n = 75), and multiple sclerosis (n = 98). RESULTS: The incidence of ulcerative colitis was significantly increased in association with PFOA exposure, with adjusted rate ratios by quartile of exposure of 1.00 (referent), 1.76 (95% CI: 1.04, 2.99), 2.63 (95% CI: 1.56, 4.43), and 2.86 (95% CI: 1.65, 4.96) (ptrend < 0.0001). A prospective analysis of ulcerative colitis diagnosed after the baseline 2005-2006 survey (n = 29 cases) suggested a positive but non-monotonic trend (ptrend = 0.21). DISCUSSION: To our knowledge, this is the first study of associations between this common environmental exposure and autoimmune diseases in humans. We found evidence that PFOA is associated with ulcerative colitis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1289/ehp.1206449

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. Baumgart, 2007, Inflammatory bowel disease: cause and immunobiology., Lancet, 369, 1627, 10.1016/S0140-6736(07)60750-8 · DOI · Paper page
  2. Bogdanos, 2012, Twin studies in autoimmune disease: genetics, gender and environment., J Autoimmun, 38, J156, 10.1016/j.jaut.2011.11.003 · DOI · Paper page
  3. Cooper, 2009, Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases., J Autoimmun, 33, 197, 10.1016/j.jaut.2009.09.008 · DOI · Paper page
  4. Davoli, 1997, Mortality among patients with ulcerative colitis: Rome 1970–1989., Eur J Epidemiol, 13, 189, 10.1023/A:1007388626476 · DOI
  5. Delgado-Vega, 2010, Recent findings on genetics of systemic autoimmune diseases., Curr Opin Immunol, 22, 698, 10.1016/j.coi.2010.09.002 · DOI
  6. DeWitt, 2008, Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice, Environ Health Perspect, 116, 644, 10.1289/ehp.10896 · DOI
  7. DeWitt, 2012, Immunotoxicity of perfluorinated compounds: recent developments, Toxicol Pathol, 40, 300, 10.1177/0192623311428473 · DOI · Paper page
  8. DeWitt, 2009, Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha., Crit Rev Toxicol, 39, 76, 10.1080/10408440802209804 · DOI · Paper page
  9. Dubuquoy, 2006, PPARγ as a new therapeutic target in inflammatory bowel diseases., Gut, 55, 1341, 10.1136/gut.2006.093484 · DOI · Paper page
  10. Frisbee, 2009, The C8 Health Project: design, methods, and participants., Environ Health Perspect, 117, 1873, 10.1289/ehp.0800379 · DOI · Paper page
  11. Fromme, 2009, Perfluorinated compounds—exposure assessment for the general population in Western countries., Int J Hyg Environ Health, 212, 239, 10.1016/j.ijheh.2008.04.007 · DOI · Paper page
  12. Gersemann, 2012, Innate immune dysfunction in inflammatory bowel disease., J Intern Med, 271, 421, 10.1111/j.1365-2796.2012.02515.x · DOI
  13. Grandjean, 2012, Serum vaccine antibody concentrations in children exposed to perfluorinated compounds., JAMA, 307, 391, 10.1001/jama.2011.2034 · DOI · Paper page
  14. Hanauer, 2006, Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities., Inflamm Bowel Dis, 12, S3, 10.1097/01.MIB.0000195385.19268.68 · DOI · Paper page
  15. Kappelman, 2013, Recent trends in the prevalence of Crohn’s Disease and ulcerative colitis in a commercially insured US population., Dig Dis Sci, 58, 519, 10.1007/s10620-012-2371-5 · DOI · Paper page
  16. Leonard, 2008, Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers., Ann Epidemiol, 18, 15, 10.1016/j.annepidem.2007.06.011 · DOI · Paper page
  17. Mahid, 2006, Smoking and inflammatory bowel disease: a meta-analysis., Mayo Clin Proc, 81, 1462, 10.4065/81.11.1462 · DOI · Paper page
  18. Mannon, 2012, Interleukin 13 and its role in gut defence and inflammation., Gut, 61, 1765, 10.1136/gutjnl-2012-303461 · DOI
  19. Miller, 2012, Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop., J Autoimmun, 39, 259, 10.1016/j.jaut.2012.05.002 · DOI · Paper page
  20. Ordas, 2012, Ulcerative colitis., Lancet, 380, 1606, 10.1016/S0140-6736(12)60150-0 · DOI · Paper page
  21. Qazi, 2009, High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion., Toxicology, 262, 207, 10.1016/j.tox.2009.06.010 · DOI
  22. Sands, 2004, From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation., Gastroenterology, 126, 1518, 10.1053/j.gastro.2004.02.072 · DOI · Paper page
  23. Shin, 2011, Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project., Environ Health Perspect, 119, 1760, 10.1289/ehp.1103729 · DOI
  24. Steenland, 2010, Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)., Environ Health Perspect, 118, 1100, 10.1289/ehp.0901827 · DOI · Paper page
  25. Steenland, 2009, Predictors of PFOA levels in a community surrounding a chemical plant., Environ Health Perspect, 117, 1083, 10.1289/ehp.0800294 · DOI
  26. Steenland, 2012, Mortality patterns among workers exposed to PFOA., Am J Epidemiol, 176, 909, 10.1093/aje/kws171 · DOI
  27. Vanden Heuvel, 2006, Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α, -β, and -γ, liver X receptor-β, and retinoid X receptor-α., Toxicol Sci, 92, 476, 10.1093/toxsci/kfl014 · DOI · Paper page
  28. Winquist, 2013, Design, methods and population for a study of PFOA health effects among highly exposed Mid-Ohio Valley community residents and workers., Environ Health Perspect, 121, 893, 10.1289/ehp.1206450 · DOI
  29. Winther, 2003, Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County., Gastroenterology, 125, 1576, 10.1053/j.gastro.2003.09.036 · DOI
  30. Woskie, 2012, Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant., Ann Occup Hyg, 56, 1025, 10.1093/annhyg/mes023 · DOI
  31. Yang, 2000, Effects of peroxisome proliferators in the thymus and spleen of mice., Clin Exp Immunol, 122, 219, 10.1046/j.1365-2249.2000.01367.x · DOI

Cited by

See all 227

Metadata

Authors
Steenland, K., Zhao, L., Winquist, A., & Parks, C.
Venue
Environmental Health Perspectives
Publisher
American Chemical Society (ACS)
Published
2013-08
Volume
121
Issue
8
Pages
900-905
ISSN
  • 0091-6765 (ISSN-L)
  • 1552-9924
DOI
10.1289/ehp.1206449
OpenAlex
W1972268723
Cited by
227
References
7
FWCI
5.62
Type
journal article
Language
en
Open access
gold
Licence
creativecommons.org/licenses/by/4.0/ (vor, 1669 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.